Iran has resumed the production of ballistic missiles utilizing hidden underground installations, according to a recent report in the Wall Street Journal, defying previous claims from United States officials that the country’s military industrial capabilities had been nearly wiped out. Despite targeted strikes by Israeli and American forces designed to dismantle these weapons programs, Tehran is actively assembling existing parts at secure subterranean locations like the Khojir complex.
Underground Facilities Drive Ballistic Missile Production Recovery
Satellite data and recent intelligence reports confirm that Iran is manufacturing both ready-to-launch solid-fuel missiles and liquid-fuel variants. According to Tal Inbar of the Missile Defense Advocacy Alliance, the cessation of active bombardments provided Tehran with the necessary window to repair damaged infrastructure and acquire foreign components. To mitigate the threat of future airstrikes, the government is also establishing additional hidden assembly centers. While current output remains below pre-war levels due to damaged factories and a restrictive naval blockade, experts note that this infrastructure recovery was largely inevitable given the decentralized design of the network.
Contradictory Official Assessments on Military Industrial Base
These findings stand in direct contrast to earlier statements issued by the American administration. Pentagon spokesperson Sean Parnell previously asserted that nearly 90 percent of Iran’s military industrial base had been destroyed, while former statements described the missile program as permanently dismantled. Intelligence now indicates that Tehran maintains thousands of missiles alongside sufficient reserves of guidance systems, frames, and warheads to construct hundreds more. This resilience stems from a decentralized blueprint established in the 1980s, which Nicole Grajewski, a specialist in Iranian strategy, notes is recovering faster than the nation’s nuclear ambitions.
Did you know? Iran continues to rely on cost-effective, mobile weapons like the Kheibar Shekan. Designed to exhaust opposing air defenses through large-scale attacks, these projectants include cluster warheads utilized in recent strikes against foreign-occupied bases in the region.
Bypassing Blockades Through Foreign Logistics
Supply lines supporting the missile network have adapted to international restrictions. Since the onset of a ceasefire, Iran has bypassed western naval blockades by importing ammunition, explosives, and drone components from Russia via the Caspian Sea. Satellite imagery confirms that logistical pathways, including bridges and tunnel access points destroyed during prior engagements, are actively being restored to support ongoing transit and assembly operations.
Frequently Asked Questions
How is Iran producing ballistic missiles despite recent airstrikes?
According to intelligence cited by the Wall Street Journal, Tehran utilizes hidden underground installations such as the Khojir complex to assemble existing parts, protecting manufacturing operations from future aerial attacks.
What did U.S. officials claim about Iran’s missile program?
Pentagon spokesperson Sean Parnell previously claimed that roughly 90 percent of Iran’s military industrial base was destroyed, a narrative contradicted by current intelligence showing active infrastructure recovery and thousands of existing missiles.
How are raw materials and components entering Iran?
Specialist analysis indicates that Iran circumvents western naval blockades by importing drone parts, explosives, and ammunition from Russia across the Caspian Sea.
Want to stay informed on global security developments? Subscribe to our weekly defense intelligence updates to receive expert analysis and breaking news directly in your inbox.
Worth a look
- EU Prepares New Crackdown on Cheap Goods from Temu and Shein
- XREAL vs URXR vs VITURE: Best AR Glasses Monitor Replacement
- Breakthrough Salk Study Uncovers Mechanism Behind Immunotherapy Resistance: Interferons, Mitochondrial Dysfunction, and PGE2″ Interferons, mitochondrial dysfunction and PGE2: Salk study reveals mechanism behind immunotherapy resistance. Boost its search engine visibility with relevant keywords for maximum impact. Immunotherapy resistance remains one of the biggest hurdles in cancer treatment. According to a recent study published in the journal Nature Communications, scientists at the Salk Institute have made a groundbreaking discovery that sheds light on the underlying mechanisms behind this resistance. The study reveals that interferons, a type of protein that plays a crucial role in the immune system, can contribute to mitochondrial dysfunction in cancer cells. This dysfunction can lead to the production of prostaglandin E2 (PGE2), a molecule that promotes tumor growth and resistance to immunotherapy. In their study, the researchers found that PGE2 production was a key factor in the development of immunotherapy resistance in cancer cells. The team used a combination of experimental and computational models to investigate the relationship between interferons, mitochondrial dysfunction, and PGE2 production. The findings of the study suggest that targeting PGE2 production could be a potential strategy for overcoming immunotherapy resistance. The researchers propose that blocking PGE2 receptors or inhibiting its production could help restore the function of mitochondria in cancer cells, making them more susceptible to immunotherapy. The study’s authors hope that their findings will pave the way for the development of new therapies that can overcome immunotherapy resistance and improve treatment outcomes for cancer patients. Key Takeaways: – Interferons contribute to mitochondrial dysfunction in cancer cells – Mitochondrial dysfunction leads to PGE2 production, promoting tumor growth and resistance to immunotherapy – Targeting PGE2 production could be a potential strategy for overcoming immunotherapy resistance – Restoring mitochondrial function in cancer cells could make them more susceptible to immunotherapy Keywords: immunotherapy resistance, interferons, mitochondrial dysfunction, PGE2, Salk Institute, cancer treatment, breakthrough study, Nature Communications. (archyworldys.com)
- Why Larry Ellison's Scrapped $7.5 Billion Stock Sale Was Never a Secret (daybreakwire.com)